Xanthogranulomatous prostatitis is a rare benign Background: inflammatory process of the prostate. Clinical, biochemical and imaging similarities make xanthogranulomatous prostatitis a difficult differential diagnosis of prostatic adenocarcinoma.
Introduction
A variety of benign conditions of the prostate can clinically mimic prostatic adenocarcinoma, thus raising a diagnostic problem. Xanthogranulomatous prostatitis, a rare form of non-specific granulomatous prostatitis, is considered among those pathologies that can clinically, biochemically and even radiologically behave as a prostate carcinoma 1, 2 . Symmers was the first author to mention this disease in 1950 3 , while Miekoś et al. produced the first case report in Poland in 1986 4, 5 . Very few similar cases have since then been described in the literature.
We report an additional case of a patient with initial clinical suspicion of prostatic carcinoma, but whose histopathological report revealed a xanthogranulomatous prostatitis.
Case report
The patient is a 62 year old diabetic male, with no particular medical history, whose main symptoms started 3 months ago with urinary incontinence, increased urinary frequency and urgency, alongside haematuria. The patient also had micturition burning, which came with a recent onset of fever. Digital rectal examination (DRE) was indolent and revealed an asymmetric and enlarged prostate, with a hard fixed nodule on the right lobe. The patient's general physical examination was normal, and revealed no alterations of the penis, the testicles or the epididymis. A prostate-specific antigen (PSA) test was performed and showed an increase in serum PSA level that reached 43.97 ng/ml (normal level <4 ng/ml). Urine analysis were within normal limits with no growth in urine culture. A transabdominal ultrasonography showed a normal upper renal tract and a normal bladder wall, with a post-micturition residual volume of 48.21 ml. Transrectal ultrasound (TRUS) was not performed, as it was too painful for the patient to sustain. From the clinical, radiological and biochemical data, a locally advanced prostate carcinoma was suspected. A multiparametric magnetic resonance imaging (mpMRI) of the prostate was then performed. The MRI showed an enlarged prostate, with an estimated weight of 51 grams. Two foci were found ( Figure 1 ), which were classified as PI-RADS 4 lesions, thus requiring histological examination. There was no infiltration of the peri-prostatic fat.
A TRUS guided prostate biopsy was then performed. A systematic 12-core prostate biopsy was realized, alongside three more core samples on zones that were found suspicious on the MRI images. Histological examination of the 15 needle biopsy core samples showed glandular atrophy, fibrosis, and an accumulation of inflammatory cells including polymorphs with eosinophils and neutrophils, with prostatic abscess, as well as the presence of foamy macrophages (lipid-laden histiocytes), also known as xanthoma cells ( Figure 2 ). Tissue cultures and immunohistochemistry tests were not performed. The histopathological examination concluded a suppurated xanthogranulomatous prostatitis, with no evidence of malignancy.
Conservative treatment was chosen, and the patient was given Ciprofloxacin for 4 weeks (500mg, twice a day). After three months, a PSA test was performed, and showed a significant decrease in PSA that reached 7.27 ng/ml (compared to the initial 43.97 ng/ml). A transabdominal ultrasonography showed a decrease in prostate volume, with an estimated prostate weight of 31 grams (versus 51 grams previously). A close follow-up will be needed for this case, with a clinical and biochemical check-up every trimester, until PSA levels are within normal limits (<4 ng/ml).
Discussion
Benign conditions that mimic prostate carcinoma have been divided into six groups 5 , among them, inflammatory diseases. Granulomatous prostatitis is an unusual prostatic entity that was first described by Tanner and McDonald in 1943 6 and classified in 1984 by Epstein and Hutchin 7 into five groups, based on aetiology and histopathology: idiopathic (non-specific), infectious (specific), malakoplakia, iatrogenic, and cases associated with systematic diseases and allergy 3, 7, 8 . Infectious agents that have been encountered in specific granulomatous prostatitis are Mycobacterium tuberculosis, Treponema pallidum, as well as some fungi and viruses 3, 8 . Specific granulomatous prostatitis may also be due to intravesical Bacillus Calmette-Guerin (BCG) therapy for bladder cancer 8 . Xanthogranulomatous prostatitis is an uncommon form of non-specific granulomatous prostatitis. The aetiology of xanthogranulomatous prostatitis is still unclear; it has been often associated with hyperlipidemia (in our case, the patient had no history of hyperlipidemia) or recurrent urinary tract infection 8 , although some authors have considered that it might be caused by an autoimmune disease with a HLA-DR15-linked T-cell response against proteins in prostatic secretions 4, 9, 10 . Bostwick and Chang brought the theory of ductal obstruction, speculating that blockage of prostate ducts and stasis of secretions cause cellular debris, bacterial toxins, prostatic secretions, sperm, and semen to escape into the stroma through the destroyed epithelium, eliciting a localized inflammatory response 4, 9, 10 .
Xanthogranulomatous inflammation occurs very rarely in the prostate. It is vastly known in the kidneys and gallbladder, and has been described in other anatomic sites, such as the mandible, retro peritoneum, third ventricle, choroid plexus, orbit, vagina, lung, stomach, pericardium, and ovary 10 . Less than 20 cases have been reported in the literature since its first description 4,9 with a similar case of suppurated xanthogranulomatous prostatitis recently discovered also in Morocco 9 .
Histologically, the typical lesion in granulomatous prostatitis is a large inflammatory nodular infiltrate of epithelioid histiocytes, plasma cells, lymphocytes and sometimes polymorphs with eosinophils 5, 9, 11 . The specific and distinctive feature of xanthogranulomatous prostatitis is the presence of foamy macrophages (lipid-laden histiocytes), also known as xanthoma cells 5, 9, 11 . Immunohistochemistry tests reveal T-lymphocytes in close association with damaged epithelium while B-lymphocytes occur in a more peripheral location or form follicular structures 9,11 . The presence of xanthoma cells may cause diagnostic confusion with high-grade prostatic carcinoma 3, 9, 12 , especially with the hypernephroid pattern of prostate carcinoma (Gleason 4B) 3 , as well as clear cell carcinoma 12 . A panel of immunohistochemistry tests, such as cytokeratin, PSA, prostatic acid phosphatase (PAP), leukocyte common antigen (LCA) and CD68 can be useful in differentiating between these two conditions, by showing results more consistent with an inflammatory process 3, 9, 11 . Those tests were not performed in our case, as the foamy macrophages were judged sufficient for the histopathological diagnosis of this condition.
In our case, even though all the signs were pointing towards prostate adenocarcinoma, we decided not to rush the diagnosis. Multi-parametric MRI was very helpful, as it allowed us to locate the suspicious foci. We decided then to perform a 15-core needle biopsy, rather than the systematic 12-core biopsy that is usually performed for prostate carcinoma, to increase our chances of finding pathological cells.
Xanthogranulomatous prostatitis causes serious confusion with prostate carcinoma when it comes to diagnosis. It occurs usually in elderly men, usually in the sixth decade 3, 8 . In most cases, xanthogranulomatous prostatitis is diagnosed incidentally on TURP chips or needle biopsy 3, 8, 9 . Clinically, the symptoms are either those of urinary obstruction, with low urinary tract symptoms, or severe low urinary tract infection symptoms. Two recent studies have shown that the most encountered symptoms were increased urinary frequency and urgency, sometimes with dysuria, micturition burns, haematuria and urinary incontinence 3, 8 . Few episodes of fever and chills have been reported 8 . On DRE, it is difficult to distinguish from prostate carcinoma, as the prostate feels hard and nodular 3, 8 . In some cases, DRE finds an asymmetry or an enlargement of the prostate. In addition, xanthogranulomatous prostatitis may cause a transient increase in serum PSA level, which decreases with a resolution of the inflammation 4, 9, 11 . In some cases, PSA serum levels reach 150 ng/ml 11 . In our case, PSA decreased from 43.97 ng/ml to 7.27 ng/ml in the space of 3 months. Furthermore, no imaging (TRUS, MRI) can differentiate between xanthogranulomatous prostatitis and prostate adenocarcinoma, given the radiological similarities, and the absence of a specific feature of xanthogranulomatous prostatitis 1, 2 . In a recent study, it has been shown that 63.6% of patients with PI-RADS (V2) 4 lesions who underwent transrectal biopsy were diagnosed with prostate cancer 13 . Hence, the only way to differentiate between these two conditions is histopathological examination.
Xanthogranulomatous prostatitis can occur in a normal gland, nodular hyperplastic gland or carcinomatous prostate. It is mostly located in the peripheral or transitional zone 3, 8 . In some cases, xanthogranulomatous prostatitis can co-exist with prostate carcinoma 3, 8, 11 .
Unlike prostatic adenocarcinoma, conservative management is the rule for xanthogranulomatous prostatitis 8, 9 . Inflammation is often self-limiting and resolves slowly over time. Surgical management may be considered if there is failure of conservative treatment, and might be needed in case of severe low urinary tract symptoms or due to occurrence of complications that may require radical prostatectomy 4, 9, 10 . However, surgical treatment of xanthogranulomatous prostatitis can lead to complications like vesical neck contraction, and might require repeated resections 12 .
Long-term follow-up is needed for patients with xanthogranulomatous prostatitis, as they require a regular clinical and biochemical check-up. MRI in xanthogranulomatous prostatitis follow-up is not required, but it might be necessary if DRE remains suspicious, or if there is no decrease in PSA serum levels. In addition, benign prostatic hyperplasia and prostatic adenocarcinoma can still occur in patients who previously dealt with xanthogranulomatous prostatitis 3, 8, 11 , thus making long-term follow-up inevitable.
Conclusion
Xanthogranulomatous prostatitis is an uncommon inflammatory pathology that can mimic prostatic carcinoma both clinically and/or biochemically. Furthermore, no radiological features can help differentiate between these two conditions. Precise histopathological examination is essential for the final diagnosis of xanthogranulomatous prostatitis.
Given clinical, biochemical and imaging similarities with prostatic carcinoma, as well as the rare nature of this condition, patients with xanthogranulomatous prostatitis raise a major diagnostic issue. Conservative treatment is the rule, with long-term follow-up needed, especially in patients with persisting elevated serum PSA values.
Consent
Written informed consent was obtained from the patient for the publication of this case report and accompanying images.
Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment? Yes

Is the case presented with sufficient detail to be useful for other practitioners? Yes
No competing interests were disclosed.
Competing Interests:
Reviewer Expertise: Genitourinary Pathology.
I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative Your article is indexed in PubMed after passing peer review Dedicated customer support at every stage For pre-submission enquiries, contact research@f1000.com
